Selective inhibition of cannabinoid CB1 receptor-evoked signalling by the interacting protein GAP43

被引:0
作者
Maroto, Irene B.
Moreno, Estefania [4 ,5 ]
Costas-Insua, Carlos [1 ,2 ,3 ]
Merino-Gracia, Javier [1 ]
Diez-Alarcia, Rebeca [6 ,7 ,8 ]
Alvaro-Blazquez, Alicia
Canales, Angeles [9 ]
Canela, Enric I. [4 ,5 ]
Casado, Vicent [4 ,5 ]
Uriguen, Leyre [6 ,7 ,8 ]
Rodriguez-Crespo, Ignacio [1 ,2 ,3 ]
Guzman, Manuel [1 ,2 ,3 ]
机构
[1] Univ Complutense Madrid, Inst Univ Invest Neuroquim IUIN, Dept Biochem & Mol Biol, Madrid 28040, Spain
[2] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid 28029, Spain
[3] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid 28034, Spain
[4] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona 08028, Spain
[5] Univ Barcelona, Inst Biomed, Barcelona 08028, Spain
[6] Univ Basque Country, Dept Pharmacol, Euskal Herriko Unibertsitatea, Leioa 48940, Spain
[7] Ctr Invest Biomed Red Salud Mental CIBERSAM, Madrid 28029, Spain
[8] Biocruces Bizkaia Hlth Res Inst, Baracaldo 48903, Bizkaia, Spain
[9] Univ Complutense Madrid, Inst Univ Invest Neuroquim IUIN, Dept Organ Chem, Madrid 28040, Spain
关键词
Cell signalling; CannabinoidCB1; receptor; Growth-associated protein of 43 kDa; Rho-associated coiled-coil containing protein; kinase; GAP-43; NEUROMODULIN; NEURITE OUTGROWTH; GROWTH; ACTIVATION; BRAIN; PHOSPHORYLATION; INTERNALIZATION; CANCER; CELLS; LOGIC;
D O I
10.1016/j.neuropharm.2023.109712
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cannabinoids exert pleiotropic effects on the brain by engaging the cannabinoid CB1 receptor (CB1R), a pre -synaptic metabotropic receptor that regulates key neuronal functions in a highly context-dependent manner. We have previously shown that CB1R interacts with growth-associated protein of 43 kDa (GAP43) and that this interaction inhibits CB1R function on hippocampal excitatory synaptic transmission, thereby impairing the therapeutic effect of cannabinoids on epileptic seizures in vivo. However, the underlying molecular features of this interaction remain unexplored. Here, we conducted mechanistic experiments on HEK293T cells co -expressing CB1R and GAP43 and show that GAP43 modulates CB1R signalling in a strikingly selective manner. Specifically, GAP43 did not affect the archetypical agonist-evoked (i) CB1R/Gi/o protein-coupled sig-nalling pathways, such as cAMP/PKA and ERK, or (ii) CB1R internalization and intracellular trafficking. In contrast, GAP43 blocked an alternative agonist-evoked CB1R-mediated activation of the cytoskeleton-associated ROCK signalling pathway, which relied on the GAP43-mediated impairment of CB1R/Gq/11 protein coupling. GAP43 also abrogated CB1R-mediated ROCK activation in mouse hippocampal neurons, and this process led in turn to a blockade of cannabinoid-evoked neurite collapse. An NMR-based characterization of the CB1R-GAP43 interaction supported that GAP43 binds directly and specifically through multiple amino acid stretches to the C -terminal domain of the receptor. Taken together, our findings unveil a CB1R-Gq/11-ROCK signalling axis that is selectively impaired by GAP43 and may ultimately control neurite outgrowth.
引用
收藏
页数:13
相关论文
共 47 条
[41]   Cannabinoid Inhibition of Macrophage Migration to the Trans-Activating (Tat) Protein of HIV-1 Is Linked to the CB2 Cannabinoid Receptor [J].
Raborn, Erinn S. ;
Cabral, Guy A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01) :319-327
[42]   Comparing adenosine A2A receptor modulation of cannabinoid CB1 receptor-mediated inhibition of GABA and glutamate release in rodent striatal nerve terminals [J].
Ferreira, Samira G. ;
Bitencourt, Rafael M. ;
Garcao, Pedro ;
Cunha, Rodrigo A. ;
Kofalvi, Attila .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2025, 61 (01)
[43]   Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission [J].
Martire, Alberto ;
Tebano, Maria Teresa ;
Chiodi, Valentina ;
Ferreira, Samira G. ;
Cunha, Rodrigo A. ;
Koefalvi, Attila ;
Popoli, Patrizia .
JOURNAL OF NEUROCHEMISTRY, 2011, 116 (02) :273-280
[44]   Characterization and distribution of binding sites for [H-3]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain [J].
RinaldiCarmona, M ;
Pialot, F ;
Congy, C ;
Redon, E ;
Barth, F ;
Bachy, A ;
Breliere, JC ;
Soubrie, P ;
LeFur, G .
LIFE SCIENCES, 1996, 58 (15) :1239-1247
[45]   Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice [J].
Rodgers, RJ ;
Evans, PM ;
Murphy, A .
BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6) :405-413
[46]   Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB1 receptor density in cell membranes: an alternative to radioligand binding methods [J].
Saumell-Esnaola, Miquel ;
Elejaga-Jimeno, Ainhoa ;
Echeazarra, Leyre ;
Borrega-Roman, Leire ;
Barrondo, Sergio ;
Lopez de Jesus, Maider ;
Gonzalez-Burguera, Imanol ;
Gomez-Caballero, Alberto ;
Goicolea, Maria Aranzazu ;
Salles, Joan ;
Garcia del Cano, Gontzal .
MICROBIAL CELL FACTORIES, 2022, 21 (01)
[47]   Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice [J].
Agoglia, Abigail E. ;
Holstein, Sarah E. ;
Eastman, Vallari R. ;
Hodge, Clyde W. .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2016, 143 :11-17